Merck 2011 at a glance

XLS

Key figures of the Merck Group

 

 

 

 

 

 

 

 

 

 

 

 

 

€ million

Pharma-
ceuticals

Chemicals

Corporate
and Other

Total

Change
in %

Total revenues

6,416.2

3,860.2

10,276.4

11

Gross margin

5,227.0

2,261.1

7,488.1

8.4

Research and development

1,248.3

268.8

1,517.1

8.6

Operating result

350.3

751.0

–116.2

985.1

–12

Exceptional items

25.1

157.1

–30.4

151.8

EBIT before depreciation and amortization (EBITDA)

1,571.7

1,305.1

–141.1

2,735.7

11

Earnings before interest and tax (EBIT)

375.4

908.1

–146.6

1,136.9

2.2

Return on sales in % (ROS: operating result/total revenues)

5.5

19.5

9.6

 

Free cash flow

1,515.1

834.0

–912.7

1,436.4

Underlying free cash flow

1,245.0

801.3

–651.7

1,394.6

–17

Total revenues by business sector

Total revenues by business sector – (excluding Corporate and Other) (bar chart)

Operating result by business sector

Operating result by business sector (bar chart)